American biopharmaceutical company, Pfizer has announced that COVID-19 vaccine would be ready for emergency use by September.
According to the pharmaceutical giant, it will begin testing of the experimental vaccine in the US next week.
This is happening a week after Germany approved its first human trial of a possible COVID-19 vaccine. The vaccine, named BNT162, was developed by Biontech, a Mainz-based company.
The company had said the vaccine would be tested in the US after the human trials in Germany.
The United Kingdom had also announced that there would be clinical trials of a potential COVID-19 vaccine.
The World Health Organisation (WHO) said there are about 20 different potential COVID-19 vaccines currently in development.
Some of the companies working on a vaccine said they are accelerating the timeline for testing as experts predict that the COVID-19 pandemic may last till 2021.
According to Worldometer, confirmed cases of COVID-19 globally have risen to 3,150,478, with 218,466 deaths. But 964,161 persons have recovered.
Share this post with your Friends on
Looking for something? Search below
You may be interested
Crystal Palace Prepare Bid For Onyedika
Webby - April 23, 2024Crystal Palace are targeting a move for Club Brugge midfielder Raphael Onyedika, reports Completesports.comOnyedika has also been linked with a…
NPFL: Rangers Fall To Rivers United, Enyimba Draw Away
Webby - April 21, 2024Leaders Rangers fell to a 2-0 defeat against Rivers United in Port Harcourt on Sunday.Fidelis Ilechukwu’s side however maintained top…
Ejuke Scores Winner In Antwerp’s Win Over Cercle Brugge
Webby - April 21, 2024Chidera Ejuke was the hero as Royal Antwerp recorded a 1-0 away win against Cercle Brugge at the Jay Breydelstadion…